Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
4.690
+0.110 (2.40%)
Aug 30, 2024, 4:00 PM EDT - Market closed
Mereo BioPharma Group Revenue
Mereo BioPharma Group had revenue of $1.00M in the twelve months ending June 30, 2024, down -88.89% year-over-year. In the year 2023, Mereo BioPharma Group had annual revenue of $10.00M.
Revenue (ttm)
$1.00M
Revenue Growth
-88.89%
P/S Ratio
n/a
Revenue / Employee
$30,303
Employees
33
Market Cap
720.41M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Community Health Systems | 12.55B |
Pacira BioSciences | 690.31M |
Travere Therapeutics | 177.64M |
Wave Life Sciences | 110.50M |
CureVac | 70.57M |
Simulations Plus | 66.98M |
Exscientia | 26.57M |
Applied Therapeutics | -333.00K |
MREO News
- 18 days ago - Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market - GlobeNewsWire
- 3 months ago - Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 months ago - Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - Newer Treatments In Alpha-1 Antitrypsin Deficiency: $2.5 Billion/Year Market Size By 2032 - Seeking Alpha
- 6 months ago - Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference - GlobeNewsWire